# Amaranth Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amaranth-medical

- Industry: Medical Devices & Equipment
- Headquarters: Mountain View, US
- Website: www.amaranthmedical.com
- Total disclosed funding: $53M
- Latest round: Series B (Oct 7, 2013)
- Investors on record: 5

## About

Amaranth Medical, Inc. is a company focused on developing innovative medical devices and therapies aimed at improving patient outcomes and addressing unmet needs in healthcare.Amaranth Medical, Inc. specializes in creating advanced medical devices, particularly in the field of interventional cardiology. The company is headquartered in Mountain View, US. It was founded by Kamal Ramzipoor, who has a history of involvement in other ventures within the medical technology sector. In January 2014, Amaranth Medical successfully raised USD 20.00 mn through a Series B funding round led by DCP Management Pte Ltd, alongside investments from Charter Life Sciences, Phillip Private Equity, SG Growth Capital Pte Ltd, and Venstar Investments. This funding round represents the total amount raised by the company to date.Amaranth Medical, Inc. offers a range of innovative products designed to enhance operational efficiency in healthcare. Their core offerings include advanced medical devices aimed at addressing specific challenges in interventional cardiology. By focusing on the needs of healthcare providers, their products are designed to improve patient outcomes through user-friendly interfaces and effective treatment solutions. The company has established a presence in key geographical markets, including North America, Europe, and parts of Asia, where the demand for their medical technologies continues to rise.Amaranth Medical, Inc. primarily generates revenue through a subscription model for its medical devices and therapies. They offer various service tiers that allow healthcare providers to select plans tailored to their operational needs. Revenue is derived from direct sales to hospitals and clinics, ensuring a consistent income stream through long-term contracts and recurring fees associated with their medical solutions.Looking ahead, Amaranth Medical plans to expand its product line with new medical devices targeting unmet clinical needs, with potential launches expected in the coming years. The company aims to enter additional markets in Europe and Asia by 2025, leveraging the recent funding from January 2014 to support these initiatives. The capital raised is earmarked for research and development, product launches, and increasing market penetration, ensuring that Amaranth Medical remains aligned with the evolving demands of the healthcare landscape.

## Funding rounds

- Series B, Oct 7, 2013, $20M — Charter Life Sciences, SG Growth Capital, Phillip Private Equity, Venstar Investments, DCP Management Pte Ltd
- Series B, Jun 13, 2013, $25M — Charter Life Sciences, SG Growth Capital, Phillip Private Equity
- Series A, Sep 26, 2006, $7.5M — Charter Life Sciences, SG Growth Capital

## Investors

- Charter Life Sciences (https://capitalatlas.ai/funds/charter-life-sciences) — Series A, Series B
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series A, Series B
- Phillip Private Equity (https://capitalatlas.ai/funds/phillip-private-equity) — Series B
- Venstar Investments (https://capitalatlas.ai/funds/venstar-investments) — Series B
- DCP Management Pte Ltd — Series B